Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Cell Dissociation Market - Global Forecast 2026-2032 | Market to Reach USD 2.17 Billion at 14.39% CAGR as Single-Cell Analysis, Cell Therapy, and Automation Accelerate

globenewswire.com

Cell Dissociation Market - Global Forecast 2026-2032 | Market to Reach USD 2.17 Billion at 14.39% CAGR as Single-Cell Analysis, Cell Therapy, and Automation Accelerate Dublin, Oct. 30, 2026 (GLOBE NEWSWIRE) -- "Cell Dissociation Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering.

The global cell dissociation market research report provides an in-depth assessment of technologies, applications, growth drivers, regional dynamics, and competitive opportunities shaping this essential life sciences workflow. Valued at a projected USD 966.37 million in 2026, the market is expected to expand at a CAGR of 14.39% to reach USD 2.17 billion by 2032. The analysis supports strategic planning by highlighting where automation, application-specific solutions, and advanced quality controls are creating new commercial opportunities.

Market Overview

Cell dissociation enables the controlled separation of tissues, organoids, spheroids, and adherent cultures into viable single-cell suspensions or defined cell clusters. Enzymatic reagents, non-enzymatic solutions, mechanical methods, and integrated processing systems are increasingly important across:

Demand is rising for contamination-controlled, tissue-specific, reproducible, and automation-compatible methods that preserve cell viability, RNA quality, surface markers, and functional phenotype.

Transformative Market Shifts

The market is moving from generalized manual protocols toward standardized, application-specific workflows. Key developments include:

These insights enable suppliers and investors to identify high-growth applications while aligning product development with downstream assay and therapeutic manufacturing requirements.

Artificial Intelligence and Digital Quality Control

Artificial intelligence is supporting protocol optimization, process monitoring, and workflow consistency. AI-enabled imaging can assess tissue fragmentation, morphology, confluency, aggregate formation, and dissociation endpoints in real time. Machine learning can evaluate relationships among tissue type, enzyme concentration, incubation time, temperature, agitation, viability, and marker preservation.

AI-assisted quality control can also detect doublets, dead-cell contamination, dissociation bias, and cell-state artifacts. These capabilities offer a practical route to risk mitigation by reducing batch variability and improving performance in tumors, neural tissues, organoids, immune-rich samples, and stem cell-derived cultures.

Regional and Economic Group Insights

Coverage of ASEAN, GCC, European Union, BRICS, G7, and NATO markets helps organizations compare research maturity, regulatory priorities, infrastructure, and market-entry conditions.

Country-Level Opportunities

The United States leads in scalable sample preparation for genomics, cancer immunology, organoids, and cell therapy. China is rapidly increasing high-throughput single-cell and stem cell applications, while Japan and South Korea show strength in regenerative medicine and advanced diagnostics. Germany, the United Kingdom, and France remain prominent in bioprocessing, genomics, neuroscience, and clinical translation. India, Brazil, Mexico, Canada, Australia, Italy, Spain, and Russia contribute additional opportunities across cancer, infectious disease, immunology, and academic research.

Strategic Priorities for Industry Leaders

Key Takeaways from This Report

Key Attributes:

Key Topics Covered:

1. Preface

1.1. Objectives of the Study

1.2. Market Definition

1.3. Market Segmentation & Coverage

1.4. Years Considered for the Study

1.5. Currency Considered for the Study

1.6. Language Considered for the Study

1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction

2.2. Research Design

2.2.1. Primary Research

2.2.2. Secondary Research

2.3. Research Framework

2.3.1. Qualitative Analysis

2.3.2. Quantitative Analysis

2.4. Market Size Estimation

2.4.1. Top-Down Approach

2.4.2. Bottom-Up Approach

2.5. Data Triangulation

2.6. Research Outcomes

2.7. Research Assumptions

2.8. Research Limitations

3. Executive Summary

3.1. Introduction

3.2. CXO Perspective

3.3. New Revenue Opportunities

3.4. Next-Generation Business Models

3.5. Industry Roadmap

4. Market Overview

4.1. Introduction

4.2. Industry Ecosystem & Value Chain Analysis

4.2.1. Supply-Side Analysis

4.2.2. Demand-Side Analysis

4.2.3. Stakeholder Analysis

4.3. Market Dynamics

4.3.1. Key Drivers

4.3.2. Key Restraints

4.3.3. Key Opportunities

4.3.4. Key Challenges

4.4. Porter's Five Forces Analysis

4.5. PESTLE Analysis

4.6. Market Outlook

4.6.1. Near-Term Market Outlook (0-2 Years)

4.6.2. Medium-Term Market Outlook (3-5 Years)

4.6.3. Long-Term Market Outlook (5-10 Years)

4.7. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective

5.2. Consumer Experience Benchmarking

5.3. Opportunity Mapping

5.4. Distribution Channel Analysis

5.5. Pricing Trend Analysis

5.6. Regulatory Compliance & Standards Framework

5.7. ESG & Sustainability Analysis

5.8. Disruption & Risk Scenarios

5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Cell Dissociation Market, by Type

7.1. Introduction

7.2. Cell Detachment

7.3. Tissue Dissociation

8. Cell Dissociation Market, by Product

8.1. Introduction

8.2. Instruments

8.2.1. Automated Dissociators

8.2.2. Manual Tissue Grinders

8.3. Kits

8.3.1. Multiplex Kits

8.3.2. Single-Use Kits

8.4. Reagents

8.4.1. Buffers

8.4.2. Enzymes

9. Cell Dissociation Market, by Tissue Type

9.1. Introduction

9.2. Connective Tissue

9.3. Epithelial Tissue

9.4. Muscle Tissue

9.5. Nervous Tissue

10. Cell Dissociation Market, by Technology

10.1. Introduction

10.2. Chemical

10.2.1. Chelating Agents

10.2.2. Osmotic Agents

10.2.3. Surfactants

10.3. Enzymatic

10.3.1. Collagenase

10.3.2. Dispase

10.3.3. DNase

10.3.4. Trypsin

10.4. Mechanical

10.4.1. Filtration

10.4.2. Shear

10.4.3. Ultrasonic

11. Cell Dissociation Market, by Application

11.1. Introduction

11.2. Cell Therapy

11.2.1. Car-T Manufacturing

11.2.2. Stem Cell Expansion

11.3. Cell-Based Research

11.4. Clinical Diagnostics

11.4.1. Flow Cytometry

11.4.2. Histopathology

11.5. Drug Screening

11.5.1. High-Throughput Screening

11.5.2. Target Validation

12. Cell Dissociation Market, by End User

12.1. Introduction

12.2. Academic & Research Institutes

12.3. Contract Research Organizations

12.4. Hospitals & Diagnostic Centers

12.5. Pharmaceutical & Biotech Companies

13. Cell Dissociation Market, by Region

13.1. Introduction

13.2. Asia-Pacific

13.3. North America

13.4. Latin America

13.5. Europe

13.6. Middle East

13.7. Africa

14. Cell Dissociation Market, by Group

14.1. Introduction

14.2. ASEAN

14.3. GCC

14.4. European Union

14.5. BRICS

14.6. G7

14.7. NATO

15. Cell Dissociation Market, by Country

15.1. Introduction

15.2. United States

15.3. Germany

15.4. China

15.5. United Kingdom

15.6. India

15.7. Japan

15.8. Russia

15.9. Brazil

15.10. Canada

15.11. Italy

15.12. Mexico

15.13. France

15.14. Spain

15.15. Australia

15.16. South Korea

16. Competitive Landscape

16.1. Market Share Analysis, 2025

16.2. Market Concentration Analysis, 2025

16.2.1. Concentration Ratio (CR)

16.2.2. Herfindahl Hirschman Index (HHI)

16.3. Recent Developments & Impact Analysis, 2025

16.4. Product Portfolio Analysis, 2025

16.5. Benchmarking Analysis, 2025

17. Company Profiles

17.1. Abcam plc

17.2. Abeomics Inc.

17.3. Becton, Dickinson and Company

17.4. Bio-Techne Corporation

17.5. Captivate Bio, LLC

17.6. Cell Signaling Technology, Inc.

17.7. Celprogen Corporation

17.8. Central Drug House. (P) Ltd.

17.9. Corning Incorporated

17.10. Genaxxon bioscience GmbH

17.11. HiMedia Laboratories Private Limited

17.12. Innovative Cell Technologies, Inc.

17.13. Lonza Group AG

17.14. Merck KGaA

17.15. Neuromics

17.16. New England Biolabs, Inc.

17.17. Novo Nordisk A/S

17.18. PAN-Biotech GmbH

17.19. Promega Corporation

17.20. REPROCELL Inc.

17.21. RWD Life Science Co., Ltd.

17.22. Sartorius AG

17.23. ScienCell Research Laboratories, Inc.

17.24. STEMCELL Group

17.25. Stemmera Inc.

17.26. Thermo Fisher Scientific Inc.

17.27. VitaCyte, LLC

17.28. VWR International, LLC

17.29. Worthington Biochemical Corporation

18. Key Experts

List of Figures [23]

List of Tables [380]

For more information about this report visit https://www.researchandmarkets.com/r/7ovbqi

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.